Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2022-11-29 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于召开2022年第六次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice for convening the 2022 sixth extraordinary general meeting of shareholders of Yifeng Pharmacy Chain Co., Ltd. It includes details about the meeting date, voting methods, agenda items, and proxy authorization. The content focuses on the announcement and procedural information for the shareholders' meeting rather than the results or minutes of the meeting. It does not contain financial statements or detailed financial performance data. The document length is about 3,133 characters, which is relatively short and consistent with a meeting notice. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or for the Annual or Extraordinary General Meeting, including notices and meeting agendas.
2022-11-29 Chinese
益丰药房关于公开发行可转换公司债券方案及预案二次修订情况说明的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the board of directors of a company regarding revisions to the plan and proposal for a public issuance of convertible corporate bonds. It details the dates and approvals of various board meetings and shareholder meetings related to the issuance plan and its amendments. The content focuses on the description and explanation of changes to the convertible bond issuance scheme and proposal, rather than presenting financial statements or results. This fits the category of a Capital/Financing Update, as it relates to company fundraising activities and capital structure changes through convertible bond issuance.
2022-11-29 Chinese
益丰药房第四届监事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company Yifeng Pharmacy Chain Co., Ltd. It details the meeting date, attendance, and voting results on several proposals, including adjustments to the convertible bond issuance plan, a revised bond issuance proposal, a special report on the use of previously raised funds, and guarantees for bank credit applications for subsidiaries. The document is a formal announcement of meeting resolutions and voting outcomes rather than a full financial report or detailed management discussion. It does not contain comprehensive financial statements or detailed financial analysis. The content aligns with announcements of board or management decisions and resolutions. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short (1926 characters), and it is not a report publication announcement or regulatory filing. Confidence is high due to clear meeting and voting details and the nature of the content.
2022-11-29 Chinese
益丰药房关于归还暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the repayment of temporarily used convertible bond funds that were used to supplement working capital. It details amounts used and repaid, references previous announcements, and includes a statement of responsibility from the board. There is no financial statement or detailed financial report included, nor is it a report publication announcement. The content relates to capital usage and financing activities, specifically the use and repayment of convertible bond proceeds. Therefore, this fits best under Capital/Financing Update (CAP). The document length is short and focused on financing updates, not a full report or regulatory filing.
2022-11-29 Chinese
关于益丰大药房连锁股份有限公司前次募集资金使用情况鉴证报告（截至2022年9月30日）
Regulatory Filings
2022-11-29 Chinese
益丰药房关于为子公司石家庄新兴药房连锁有限公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Yifeng Pharmacy Chain Co., Ltd. regarding providing a guarantee for a bank credit application by its subsidiary, Shijiazhuang Xinxing Pharmacy Chain Co., Ltd. It details the guarantee amount, the subsidiary's financial data, the necessity and rationality of the guarantee, and the board's opinion. The document is short (2020 characters) and focuses on a specific financing-related guarantee event rather than a full financial report or earnings release. It does not contain financial statements or comprehensive financial analysis but is an announcement of a financing-related guarantee. Therefore, it fits best under Capital/Financing Update (CAP).
2022-11-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.